Infants’ Ibuprofen oral suspension recalled

Tris Pharma, Inc. has voluntarily recalled three (3) lots of Infants' Ibuprofen Concentrated Oral Suspension, USP (NSAID) 50 mg per 1.25 mL, to the retail level. The recalled lots of the product have been found to potentially have higher concentrations of ibuprofen. There is a remote possibility that infants, who may be more susceptible to ["]

The post Infants' Ibuprofen oral suspension recalled appeared first on Outbreak News Today.